Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial Medical Journal Nov 1 Written By Abby Hunt Vicki L. Schnell MD, Liesl K. Bredeson, Eric Brown, Anna Chan PharmD, James Thomas, James Simon, Michael C. Snabes. Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial. AJOG Global Reports. 2025 Nov; 5(4). 10.1016/j.xagr.2025.100578. Abby Hunt
Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial Medical Journal Nov 1 Written By Abby Hunt Vicki L. Schnell MD, Liesl K. Bredeson, Eric Brown, Anna Chan PharmD, James Thomas, James Simon, Michael C. Snabes. Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial. AJOG Global Reports. 2025 Nov; 5(4). 10.1016/j.xagr.2025.100578. Abby Hunt
